Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Agilent Technologies Invests US $725 million on Manufacturing Facility Expansion in USA
Agilent Technologies invested $725 million, to double the facility in Frederick, Colorados manufacturing capability for therapeutic nucleic acids A increasing number of diseases, including cancer, cardiovascular disease, rare diseases, and infectious diseases, require the use of active pharmaceutical
Ardena to Expand Manufacturing Facility in Sweden
Ardena is nearly tripling the size of its Swedish facility, as part of a US $ 37 million investment across its European operations The company is making investments in the production of drug substances in Sdertlje in order to increase capacity These include a new production line, a larger preparative High
Thermo Fisher Scientific Invests US $59 million for Laboratory Expansion in USA
Thermo Fisher Scientific has invested US $ 59 million for the expansion of its laboratory operations in Highland Heights, Kentucky, USA With this expansion, Thermo Fischer will be able to deliver lifechanging medicines to patients The current facility, at 71,600sqft, will grow to 114,000sqft and be completed in stages by the end of 2024
Almac Group Invests US $65 million for Clinical Facility Expansion in the USA
In order to expand its clinical supply operations, Almac Group invested US $65 million at the companys North American headquarters in Souderton, Pennsylvania With additional cold and ultralow storage and justintime processing capabilities, the 100,000 ft2 facility will increase the facilitys clinical capacity
Synthego Begins Work on a Manufacturing Facility in the USA
Synthego has started work on a 20,000squarefoot manufacturing facility in the USA The facility, which will be situated in the San Francisco Bay region, will enable the company to enhance the manufacturing of its gene editing tools by expanding the Halo platform
WuXi STA Begins Pharmaceutical Manufacturing Facility Construction in USA
WuXi STA has begun construction of a new 190acre pharmaceutical manufacturing campus in Middletown, Delaware, in the United States This location will be WuXi STAs second in the country, providing increased flexibility and capacity to meet the demands of clients in the US and beyond
Catalent Invests US$ 2.2 million for Clinical Supply Facility in Singapore
Catalent invested US$22 million for the expansion of its clinical supply facilities in Singapore The investment will allow the installation of 35 new freezers for ultralow temperature ULT storage, expanding the sites footprint by over 20 to 31,000 square feet
Merck Invests more than US$130 million for Manufacturing Facility Expansion in France
Merck has invested more than US$130 million to improve its production capabilities for singleuse assemblies in Molsheim, France The expansion will boost production capabilities for singleuse assemblies from the Mobius portfolio
First North American Biomanufacturing Facility Opened in USA by WuXi Biologics
WuXi Biologics opened MFG18, its first GMP phase I drug substance clinical production facility, in Cranbury, New Jersey, USA With solely singleuse technology, the 154,448 square foot sites operational capacity for clinical manufacture will increase to 6,000 litres from its initial capacity of 4,000 litres
Horizon Therapeutics to Expand its Development, Manufacturing Facility in Ireland
Horizon Therapeutics plans to increase the size of its manufacturing and development facility in Waterford, Ireland The facility will increase the companys current 44,000 square foot drug product fillfinish biologics facility by about 320,000 square feet
